paclitaxel has been researched along with Amyotonia Congenita in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhry, V; Cornblath, DR; Donehower, RC; Ettinger, DS; Forastiere, AA; Grochow, LB; Lubejko, BG; Rowinsky, EK; Sartorius, SE | 1 |
| Hoque, A; Jones, DV; Lozano, R; Markowitz, A; Patt, YZ | 1 |
| Furuse, K; Kunitoh, H; Noda, K; Ogawa, M; Saijo, N | 1 |
| Canfield, VA; Geyer, CE; Goodwin, DK; Green, SJ; Martino, S; Meyers, FJ; Moinpour, CM; O'Sullivan, J; Osborne, CK | 1 |
| Iñiguez, C; Larrodé, P; Mauri, JA; Mayordomo, JI; Morales, F; Trés, A | 1 |
1 review(s) available for paclitaxel and Amyotonia Congenita
| Article | Year |
|---|---|
[Peripheral nervous system neurotoxicity secondary to chemotherapy treatment] .
Topics: Anti-HIV Agents; Antineoplastic Agents; Cyclosporine; Depsipeptides; Docetaxel; Doxorubicin; Humans; Neoplasms; Neuromuscular Diseases; Oligopeptides; Organoplatinum Compounds; Paclitaxel; Peripheral Nervous System Diseases; Procarbazine; Reverse Transcriptase Inhibitors; Suramin; Taxoids; Vinca Alkaloids | 2000 |
3 trial(s) available for paclitaxel and Amyotonia Congenita
| Article | Year |
|---|---|
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Least-Squares Analysis; Male; Middle Aged; Neoplasms; Neuromuscular Diseases; Paclitaxel | 1993 |
Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Biliary Tract Neoplasms; Drug Administration Schedule; Female; Gallbladder Neoplasms; Humans; Male; Middle Aged; Neuromuscular Diseases; Paclitaxel; Remission Induction | 1996 |
Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Hypersensitivity; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Middle Aged; Neuromuscular Diseases; Paclitaxel; Pain Measurement; Palliative Care; Survival Analysis; Treatment Failure | 1998 |
1 other study(ies) available for paclitaxel and Amyotonia Congenita
| Article | Year |
|---|---|
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Arthralgia; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Muscles; Neuromuscular Diseases; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies | 1998 |